Background: Health status and the needs presented by people admitted to nursing homes make it necessary to contemplate aspects such as prognosis to offer quality palliative care. Objective: To compare the prognostic utility in nursing homes of two prognostic models of 6-month survival based on the Palliative Prognostic Index (PPI) or Palliative Performance Status (PPS) instruments and palliative needs indicators. Methods: A longitudinal prospective observational and analytical cohort study of survival and prognostic models in 88 patients with palliative needs (assessed by the NECPAL-ICO-CCOMS©) from an Andalusian (Spain) nursing home was performed. Sociodemographic and clinical variables were assessed, and 6 months later, in September 2017, survival was checked. Multiple logistic regression analysis was performed using the R-Commander program (version 3.2.2). Results: Two models of the logistic regression analysis met the fit criteria. The two models combined the Surprise Question, the presence of persistent symptoms, and the clinical indicators of severity from the NECPAL tool, in addition to the Charlson Comorbidity Index, and varied only in terms of the latter variable, including the PPI in the first model and the PPS in the second. In the first model, significant associations were identified between 6-month survival and the persistent symptoms variable (OR = 7.78, p = 0.025, 95% CI = 1.45–60.92) and PPI (OR = 1.94, p < 0.001, 95% CI = 1.21). In the second model, 6-month survival was also significantly associated with the persistent symptoms variable (OR = 4.57, p = 0.045, 95% CI = 1.07–22.41) and the PPS (OR = 0.93, p = 0.001, 95% CI = 0.88–0.96). Conclusions: Prognostic models such as ours that include variables commonly included in clinical assessments can help nursing home professionals prioritize and ensure adequate mobilization of palliative care resources, which are very limited in these institutions.

1.
Guardia-Mancilla P, Montoya-Juárez R, Martí-García C, Herrero-Hahn R, García-Caro MP, Cruz-Quintana F: Perceptions of health care professionals about end-of-life care, obstacles and ethical dilemmas in hospitals, primary care and nursing homes. An Sist Sanit Navar 2018; 41: 35–46.
2.
Vetrano DL, Collamati A, Magnavita N, Sowa A, Topinkova E, Finne-Soveri H, et al: Health determinants and survival in nursing home residents in Europe: results from the SHELTER study. Maturitas 2018; 107: 19–25.
3.
Van der Steen JT, Radbruch L, Hertogh CM, de Boer ME, Hughes JC, Larkin P, et al. White paper defining optimal palliative care in older people with dementia: a Delphi study and recommendations from the European Association for Palliative Care. Palliat Med 2014; 28: 197–209.
4.
Froggatt K, Payne S, Morbey H, Edwards M, Finne-Soveri H, Gambassi G, et al: Palliative care development in European care homes and nursing homes: application of a typology of implementation. J Am Med Dir Assoc 2017; 18: 550.e7–550.e14.
5.
Gómez-Batiste X, Martínez-Muñoz M, Blay C, Amblàs J, Vila L, Costa X: Identificación de personas con enfermedades crónicas avanzadas y necesidad de atención paliativa en servicios sanitarios y sociales: elaboración del instrumento NECPAL CCOMS-ICO©. Med Clin (Barc) 2013; 140: 241–245.
6.
Hadique S, Culp S, Sangani RG, Chapman KD, Khan S, Parker JE, et al: Derivation and validation of a prognostic model to predict 6-month mortality in an intensive care unit population. Ann Am Thorac Soc 2017; 14: 1556–1561.
7.
Gómez-Batiste X, Martínez-Muñoz M, Blay C, Amblàs J, Vila L, Costa X, et al: Utility of the NECPAL CCOMS-ICO© tool and the Surprise Question as screening tools for early palliative care and to predict mortality in patients with advanced chronic conditions: a cohort study. Palliat Med 2017; 31: 754–763.
8.
Nieto Martín MD, Bernabeu Wittel M, De La Higuera Vila L, Mora Rufete A, Barón Franco B, Ollero Baturone M: Recalibración del Palliative Prognostic Index en pacientes con enfermedades médicas avanzadas. Rev Clin Esp 2013; 213: 323–329.
9.
Anderson F, Downing GM, Hill J, Casorso L, Lerch N: Palliative performance scale (PPS): a new tool. J Palliat Care 1996; 12: 5–11.
10.
White N, Kupeli N, Vickerstaff V, Stone P: How accurate is the “Surprise Question” at identifying patients at the end of life? A systematic review and meta-analysis. BMC Med 2017; 15: 139.
11.
Mercadante S, Valle A, Porzio G, Aielli F, Adile C, Casuccio A: Prognostic factors of survival in patients with advanced cancer admitted to home care. J Pain Symptom Manage 2013; 45: 56–62.
12.
Charlson ME, Pompei P, Ales KL, MacKenzie CR: A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40: 373–383.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.